In the recent years the Indian Economy has continued to deliver a standout performanceand grow at a rapid pace. At the same time however ensuring access to quality healthcareremains a primary challenge for governments and communities. We truly believe thatdelivering good health requires more than just good products. In order to deliver goodhealth we must build a business which is robust around processes that are best-in-classand with a mindset that is long-term while investing in high-quality assets and the bestpeople.
The Indian pharma industry has been growing at a compounded annual growth rate (CAGR)of more than 15% over the last five years and has significant growth opportunities.However for the industry to sustain this robust growth rate till 2020 companies willhave to rethink their business strategy. They will have to adopt new business models andthink of innovative ideas to service their evolving customers faster and better.
Despite of the challenges being faced by the Company during current Financial Yearthe Company has been able to explore new markets and improve its Exports Performance.While things are changing the journey is still a long one. I am confident that theCompany will manage to survive through these challenging times with the positive approachand relentless efforts of the Management and the Employees of the Company.
The Board and I are truly grateful for the support that we continue to receive from allour stakeholders.